Sponsors (15)
The bill promises a fast, detailed federal review to produce actionable, transparent findings that can improve veteran suicide prevention and clinical practice, but it raises significant privacy, resource, cost, and reputational risks that must be managed.
Veterans: a mandated, comprehensive federal review of veteran suicides to be completed within 18 months will produce actionable findings to guide targeted suicide‑prevention and safety reforms.
Veterans and people with disabilities: the review will identify prevalence of combat exposure, MST, TBI, and PTSD among decedents, informing improvements in trauma‑informed clinical care and prevention programs.
Patients, families, researchers, and policymakers: public release of findings within 30 days increases transparency and gives stakeholders rapid access to results for oversight, advocacy, and policy development.
Veterans, VA staff, and taxpayers: conducting a detailed, rapid national review will impose substantial administrative workload and may force VA staff to divert time from clinical duties, creating operational strain.
Veterans and people with disabilities: public release of granular medication, diagnosis, and facility data creates risk of exposing sensitive personal health information unless de‑identification safeguards are robust.
Taxpayers and the VA: the extensive review and public reporting will incur additional administrative costs that require VA funding or budget reallocation, potentially reducing funds for other services.
Based on analysis of 2 sections of legislative text.
Requires the VA Secretary to complete within 18 months a public review of suicides among veterans who received VA care in the prior five years, detailing demographics, medications, diagnoses, facility patterns, and recommendations.
Introduced December 18, 2025 by Andrew R. Garbarino · Last progress December 18, 2025
Requires the Secretary of Veterans Affairs to complete and publicly release, within 18 months of enactment, a comprehensive review of suicides among veterans who received VA hospital care or medical services during the five years before their deaths. The review must count total suicides, summarize demographics, list medications prescribed or detected (flagging high‑risk types), report related diagnoses and polypharmacy, identify facilities with high prescribing and suicide rates, describe VA prescribing policies, note apparent patterns, and include recommendations to address findings.